Skip to main content
Erschienen in: Journal of Cancer Education 4/2020

16.03.2019

Relationships Between Fear of Cancer Recurrence and Lifestyle Factors Among Cancer Survivors

verfasst von: Sarah C. Reed, Janice F. Bell, Diana L. Miglioretti, Larissa Nekhlyudov, Nathan Fairman, Jill G. Joseph

Erschienen in: Journal of Cancer Education | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

We examine the relationships between fear of cancer recurrence (FCR), physical activity, smoking status, and engagement in healthier habits in a US population-based sample of post-treatment cancer survivors. We used data from the 2011 Medical Expenditure Panel Survey (MEPS) Experience with Cancer Survivorship Supplement. Multivariable logistic regression was used to test the relationship of FCR to physical activity, smoking status, and engagement in healthier habits. In all analyses, MEPS survey weights were applied to account for the survey design. Compared with those reporting no FCR, survivors reporting high FCR had significantly lower odds of reporting that they were not currently smokers (odds ratio [OR] = 0.46; 95% CI 0.24, 0.91) and those with any level of FCR had significantly higher odds of reporting healthier habits since diagnosis relative to those with no FCR (low FCR OR = 1.97; 95% CI 1.36, 2.85; high FCR OR = 2.40; 95% CI 1.33, 4.32). FCR was not associated with the odds of reporting physical activity. Findings from this large population-based survey suggest that some of survivors’ lifestyle factors may be related to their level of FCR. Understanding the effects of FCR on lifestyle factors may help survivors, survivorship care providers, and policy makers better understand important differences among cancer survivors and personalize interventions in clinical care.
Literatur
14.
Zurück zum Zitat Underwood JM, Townsend JS, Stewart SL, Buchannan N, Ekwueme DU, Hawkins NA et al (2012) Surveillance of demographic characteristics and health behaviors among adult cancer survivors—Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ 61(1):1–23PubMed Underwood JM, Townsend JS, Stewart SL, Buchannan N, Ekwueme DU, Hawkins NA et al (2012) Surveillance of demographic characteristics and health behaviors among adult cancer survivors—Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ 61(1):1–23PubMed
15.
Zurück zum Zitat Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Ligibel JA, McCabe MS, McVary KT, Melisko M, Montoya JG, Mooney K, Morgan MA, O’Connor T, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D (2014) Survivorship: introduction and definition: clinical practice guidelines in oncology. J Natl Compr Cancer Network : JNCCN 12(1):34–45CrossRef Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Ligibel JA, McCabe MS, McVary KT, Melisko M, Montoya JG, Mooney K, Morgan MA, O’Connor T, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D (2014) Survivorship: introduction and definition: clinical practice guidelines in oncology. J Natl Compr Cancer Network : JNCCN 12(1):34–45CrossRef
16.
Zurück zum Zitat Linsky A, Nyambose J, Battaglia TA (2011) Lifestyle behaviors in Massachusetts adult cancer survivors. J Cancer Surviv 5(1):27–34CrossRef Linsky A, Nyambose J, Battaglia TA (2011) Lifestyle behaviors in Massachusetts adult cancer survivors. J Cancer Surviv 5(1):27–34CrossRef
21.
Zurück zum Zitat Demark-Wahnefried W, Rogers LQ, Alfano CM, Thomson CA, Courneya KS, Meyerhardt JA, Stout NL, Kvale E, Ganzer H, Ligibel JA (2015) Practical clinical interventions for diet, physical activity, and weight control in cancer survivors. CA Cancer J Clin 65(3):167–189. https://doi.org/10.3322/caac.21265 CrossRefPubMed Demark-Wahnefried W, Rogers LQ, Alfano CM, Thomson CA, Courneya KS, Meyerhardt JA, Stout NL, Kvale E, Ganzer H, Ligibel JA (2015) Practical clinical interventions for diet, physical activity, and weight control in cancer survivors. CA Cancer J Clin 65(3):167–189. https://​doi.​org/​10.​3322/​caac.​21265 CrossRefPubMed
22.
25.
Zurück zum Zitat Irwin ML, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A, Chung GG, DiPietro L, Mayne ST, Yu H (2009) Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epidemiol Biomark Prev 18(1):306–313. https://doi.org/10.1158/1055-9965.Epi-08-0531 CrossRef Irwin ML, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A, Chung GG, DiPietro L, Mayne ST, Yu H (2009) Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epidemiol Biomark Prev 18(1):306–313. https://​doi.​org/​10.​1158/​1055-9965.​Epi-08-0531 CrossRef
30.
Zurück zum Zitat Leventhal H, Brissette I, Leventhal EA (2003) The common-sense model of self-regulation of health and illness. The self-regulation of health and illness behaviour, vol 1, pp 42–65 Leventhal H, Brissette I, Leventhal EA (2003) The common-sense model of self-regulation of health and illness. The self-regulation of health and illness behaviour, vol 1, pp 42–65
36.
Zurück zum Zitat Stull VB, Snyder DC, Demark-Wahnefried W (2007) Lifestyle interventions in cancer survivors: designing programs that meet the needs of this vulnerable and growing population. J Nutr 137(1 Suppl):243s–248sCrossRef Stull VB, Snyder DC, Demark-Wahnefried W (2007) Lifestyle interventions in cancer survivors: designing programs that meet the needs of this vulnerable and growing population. J Nutr 137(1 Suppl):243s–248sCrossRef
43.
52.
Zurück zum Zitat National Center for Chronic Disease P, Health Promotion Office on S, Health. Reports of the Surgeon General (2014) The health consequences of smoking-50 years of progress: a report of the surgeon general. Centers for Disease Control and Prevention (US), Atlanta (GA) National Center for Chronic Disease P, Health Promotion Office on S, Health. Reports of the Surgeon General (2014) The health consequences of smoking-50 years of progress: a report of the surgeon general. Centers for Disease Control and Prevention (US), Atlanta (GA)
63.
Zurück zum Zitat Ligibel JA, Denlinger CS (2013) New NCCN guidelines for survivorship care. J Natl Compr Cancer Netw 11(5 Suppl):640–644CrossRef Ligibel JA, Denlinger CS (2013) New NCCN guidelines for survivorship care. J Natl Compr Cancer Netw 11(5 Suppl):640–644CrossRef
69.
Zurück zum Zitat McBride CM, Emmons KM, Lipkus IM (2003) Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res 18(2):156–170CrossRef McBride CM, Emmons KM, Lipkus IM (2003) Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res 18(2):156–170CrossRef
Metadaten
Titel
Relationships Between Fear of Cancer Recurrence and Lifestyle Factors Among Cancer Survivors
verfasst von
Sarah C. Reed
Janice F. Bell
Diana L. Miglioretti
Larissa Nekhlyudov
Nathan Fairman
Jill G. Joseph
Publikationsdatum
16.03.2019
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 4/2020
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-019-01509-2

Weitere Artikel der Ausgabe 4/2020

Journal of Cancer Education 4/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.